Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results

    NEXT STORY
    Immunomedics Appoints Robert W. Azelby to Board of Directors
    PREV STORY
    Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VBL Therapeutics Receives Milestone Payment From NanoCarrier Under Licensing Agreement for VB-111 in Japan

    - Per agreement, milestone payments can exceed $100 million, in addition to double-digit million ...

    author_avatar
    NASDAQ Market News

    RAPT Therapeutics to Participate in Two Investor Conferences in March

    author_avatar
    NASDAQ Market News

    Heat Biologics and OncoSec Present Data at the American Conference for Cancer Research (AACR) Annual Meeting

    DURHAM, N.C., April 18, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an ...

    author_avatar
    NASDAQ Market News